SAM.gov140D0426Q0826
Open
Element Biosciences AVITI¿ 24 sequencing and spati
- Response deadline
- Aug 27, 2026 Closed
- Date posted
- Aug 11, 2026
- Source
- Open notice
Description
The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF).
Classifications
Documents (2)
Contacts
- jose_gomez@ibc.doi.gov0000000000
Similar contracts
- GEMINI.HP.L.ASY: interferometer, Gemini-Felix, and PDM moduleTennesseeDue Oct 22, 2026
- https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=95d77d8e8c4e46f592517ab556793cf0New YorkDue Oct 23, 2026
- Spectro Maxx PM ServicePennsylvaniaDue Oct 22, 2026
- Testing of Lunar Regolith Stimulant Thermal PropertiesDue Oct 20, 2026
- Notice of Intent DNA SynthesizerMarylandDue Nov 2, 2026
- ION ChromatographyDue Oct 20, 2026